Bulletin
Investor Alert

Smith & Nephew PLC ADR

NYS: SNN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 18, 2020, 4:00 p.m.

SNN
/zigman2/quotes/203117274/composite

$

39.31

Change

0.00 0.00%

Volume

Volume 3,483

Quotes are delayed by 20 min

/zigman2/quotes/203117274/composite

Previous close

$ 40.31

$ 39.31

Change

-1.00 -2.48%

Day low

Day high

$39.22

$40.34

Open

52 week low

52 week high

$26.07

$52.26

Open

Company Description

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following busines...

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Valuation

P/E Current

28.76

P/E Ratio (with extraordinary items)

43.57

P/E Ratio (without extraordinary items)

34.06

Price to Sales Ratio

3.99

Price to Book Ratio

4.13

Price to Cash Flow Ratio

17.51

Enterprise Value to EBITDA

14.57

Enterprise Value to Sales

4.32

Total Debt to Enterprise Value

0.09

Efficiency

Revenue/Employee

228,353.00

Income Per Employee

26,666.00

Receivables Turnover

4.18

Total Asset Turnover

0.60

Liquidity

Current Ratio

2.06

Quick Ratio

1.03

Cash Ratio

0.18

Profitability

Gross Margin

70.22

Operating Margin

20.01

Pretax Margin

14.44

Net Margin

11.68

Return on Assets

7.05

Return on Equity

12.20

Return on Total Capital

15.49

Return on Invested Capital

9.20

Capital Structure

Total Debt to Total Equity

39.82

Total Debt to Total Capital

28.48

Total Debt to Total Assets

22.01

Long-Term Debt to Equity

38.42

Long-Term Debt to Total Capital

27.48

Officers and Executives

Name Age Officer Since Title
Mr. Roberto Quarta 70 2013 Chairman-Elect
Mr. Roland D. Diggelmann 51 2018 Chief Executive Officer & Non-Executive Director
Mr. Mark Gladwell 44 2018 President-Global Operations
Ms. Anne-Francoise Nesmes 48 2020 Chief Financial Officer & Executive Director
Dr. Vasant Padmanabhan 53 2016 President-Research & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
/news/latest/company/us/snn

MarketWatch News on SNN

  1. Smith & Nephew swings to loss over virus hit

    2:22 a.m. July 29, 2020

    - MarketWatch.com

  2. Smith & Nephew sees Covid-19 hitting revenue

    2:40 a.m. July 1, 2020

    - MarketWatch.com

  3. Smith & Nephew warns of substantial virus hit

    2:29 a.m. May 6, 2020

    - MarketWatch.com

  4. Smith & Nephew withdraws guidance

    2:39 a.m. March 30, 2020

    - MarketWatch.com

  5. Smith & Nephew says outlook hinges on coronavirus

    3:32 a.m. Feb. 20, 2020

    - MarketWatch.com

  6. Smith & Nephew guides higher on earnings

    3:02 a.m. May 2, 2019

    - MarketWatch.com

  7. Avis Budget Stock Soars and 4 More Midday Movers

    1:52 p.m. Feb. 11, 2019

    - Barron's Online

  8. Smith & Nephew profit falls on restructuring costs

    3:30 a.m. Feb. 7, 2019

    - MarketWatch.com

  9. Smith & Nephew revenue up, backs outlook

    3:12 a.m. Nov. 1, 2018

    - MarketWatch.com

  10. Smith & Nephew pretax profit falls, backs outlook

    3:04 a.m. July 26, 2018

    - MarketWatch.com

  11. Smith & Nephew cuts guidance on mixed performance

    2:19 a.m. May 3, 2018

    - MarketWatch.com

  12. Smith & Nephew appoints new CEO

    2:33 a.m. April 4, 2018

    - MarketWatch.com

  13. Loading more headlines...
/news/nonmarketwatch/company/us/snn

Other News on SNN

  1. Pandemic Spoils Food Industry Results: Earnings at a Glance

    6:09 p.m. July 29, 2020

    - The Wall Street Journal Interactive Edition

  2. Smith+Nephew's Regeneten Implant CE Mark'd

    7:14 a.m. June 16, 2020

    - Seeking Alpha

  3. Stryker: A High-Quality Buy

    9:23 p.m. March 30, 2020

    - Seeking Alpha

  4. Raymond James likes Amgen in premarket analyst action

    8:06 a.m. March 30, 2020

    - Seeking Alpha

  5. PLUG, Z among premarket gainers

    10:17 a.m. Feb. 20, 2020

    - Seeking Alpha

  6. 3 High-Performing Securities to Consider

    11:56 a.m. Feb. 4, 2020

    - GuruFocus.com

  7. Stereotaxis: Poised For A Strong 2020

    10:43 p.m. Jan. 12, 2020

    - Seeking Alpha

  8. Stryker Continues To Cut A Swath Through Med-Tech

    10:00 a.m. Jan. 8, 2020

    - Seeking Alpha

  9. Zimmer Biomet Showing Long-Awaited Progress In Its Turnaround

    9:30 a.m. Jan. 8, 2020

    - Seeking Alpha

  10. Best Big-Cap Stocks To Buy

    12:55 a.m. Jan. 4, 2020

    - Seeking Alpha

  11. Wright Medical cut at Jefferies as higher bid looks unlikely

    9:02 a.m. Dec. 24, 2019

    - Seeking Alpha

  12. Smith & Nephew's Study Outcomes for REGENETEN Encouraging

    9:39 a.m. Nov. 20, 2019

    - Zacks.com

  13. Loading more headlines...

At a Glance

Smith & Nephew Plc

Croxley Park

Hatters Lane

Building 5

Watford, Herefordshire WD18 8YE

Phone

44 1923477100

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$4.03B

Net Income

$470.32M

2019 Sales Growth

9.5%

Employees

17,637

/news/pressrelease/company/us/snn

Press Releases on SNN

  1. Medical Disposable Market to witness high growth in near future

    1:26 p.m. Sept. 17, 2020

    - Market Insight Reports

  2. Loading more headlines...
Link to MarketWatch's Slice.